Vázquez-Flores AD, Vázquez-Flores J, Zaldivar-Clavellina AK, Cortés-Contreras DK, Lule-Alatorre KP, Domínguez-Borgua A, Valenzuela-Plata A, Arellano-Estrada JM, Reyes-Ávila A

Language: Spanish
References: 17
Page: 734-737
PDF size: 400.47 Kb.

ABSTRACT

The coexistence of two or more connective tissue diseases in a patient is little frequent, particularly the coexistence of systemic lupus erythematosus and rheumatoid arthritis, disease nominated rhupus. This is a little frequent entity, there are less than 150 cases reported in literature, with prevalence of 0.09%. This paper reports the case of a 67-year-old female patient with manifestations of systemic lupus erythematosus and rheumatoid arthritis.

REFERENCES

1. Amezcua-Gerra LM. Overlap between systemic lupus erythematosus and rheumatoid arthritis: is it real or just an illusion? J Rheumatol 2009;36:4-6.

2. Simon JA, Alcocer-Varela J. ¿Cuál es la definición de rhupus? Rev Mex Reum 2001;16:111-119.

3. Banwari S. Rhupus: Report of 3 cases. J Indian Rheumatol Assoc 2003;11:51-54.

4. Alarcón-Segovia D, Abud-Mendoza C, Diaz-Jouanen E, Iglesias A, et al. Deforming arthropathy of the hands in systemic lupus erythematosus. J Rheumatol 1988;15:65-69.

5. Simon JA, Granados J, Cabiedes J, Ruiz Morales J, Alcocer- Varela J. Clinical and immunogenetic characterization of Mexican patients with ‘Rhupus’. Lupus 2002;11:287-292.

6. Toone E, Irby R, Pierce EL. The cell LE in rheumatoid arthritis. Am J Med Sci 1960;240:599-608.

7. Amezcua-Gerra LM, Springal R, Marquez-Velazco R, Gómez- Garcia L, et al. Presence of antibodies against cyclic citrullinated peptides in patients with ‘rhupus’: a cross-sectional study. Arthritis Res Ther 2006;8:R144.

8. Bukhari M, Lunt M, Harrison BJ, Scott DG, Symmons DP, Silman AJ. Rheumatoid factor is the major predictor of increasing severity of radiographic erosions in rheumatoid arthritis: results from the Norfolk Arthritis Register Study, a large inception cohort. Arthritis Rheum 2002;46:906- 912.

9. Chan M, Owen P, Dunphy J, Cox B, et al. Associations of erosive arthritis with anti-cyclic citrullinated peptide antibodies and MHC class II alleles in systemic lupus erythematosus. J Rheumatol 2008;35:77-83.

10. Hoffman IE, et al. Presence of rheumatoid factor and antibodies to citrullinated peptides in systemic lupus erythematosus. Ann Rheum Dis 2005;64:330-332.

11. Amezcua-Gerra L, Marquez-Velazco R, Bojalil R. Erosive arthritis in systemic lupus erythematosus is associated with high serum C-reactive protein and anticyclic citrullinated peptide antibodies. Inflamm Res 2008;57:555-557.

12. Benavente I, Paira S. Rhupus: Report of 4 cases. Reumatol Clin 2011;7:333-335.

13. Panush R, Edwards NL, Longley S, Webster E. ‘Rhupus’ syndrome. Arch Intern Med 1988;148:1633-1636.

14. Soforo E, Baumgartner M, Francis L, Allam F, et al. Induction of systemic lupus erythematosus with tumor necrosis factor blockers. J Rheumatol 2010;37:204-205.

15. Chogle AR, Shah CV, Murthy AK. Role of anti-tumor necrosis factor-a blockers in inducing lupus erythematosus tumidus in “rhupus syndrome”. J Rheumatol 2011;38:1218-1219.

16. Jacob N, Jacob CO. Genetics of rheumatoid arthritis: an impressionist perspective. Rheum Dis Clin North Am 2012;38:243-257.

17. Benavente E, Paira S. Micofenolato mofetil en el tratamiento del rhupus. Rev Arg Reumatol 2012;23:52-58.